HighTower Trust’s Novartis NVS Stock Holding History

HighTower Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-38,384	Closed	-$4.34M	–	301
2022 Q2	$4.34M	Buy	+38,384	New	+$3.37M	0.45%	42
2017 Q3	–	Sell	-6,506	Closed	-$487K	–	118
2017 Q2	$487K	Sell	6,506 -542	-8%	-$38.4K	0.06%	89
2017 Q1	$469K	Sell	7,048 -619	-8%	-$41.2K	0.05%	107
2016 Q4	$500K	Hold	7,667	–	–	0.06%	106
2016 Q3	$542K	Hold	7,667	–	–	0.06%	101
2016 Q2	$567K	Buy	7,667 +458	+6%	+$31.6K	0.06%	97
2016 Q1	$468K	Buy	7,209 +50	+0.7%	+$3.4K	0.06%	95
2015 Q4	$552K	Sell	7,159 -1,075	-13%	-$85.4K	0.07%	94
2015 Q3	$678K	Hold	8,234	–	–	0.11%	70
2015 Q2	$726K	Buy	8,234 +874	+12%	+$80.2K	0.12%	62
2015 Q1	$650K	Sell	7,360 -140	-2%	-$12.4K	0.1%	69
2014 Q4	$623K	Buy	7,500 +201	+3%	+$16.7K	0.09%	75
2014 Q3	$616K	Sell	7,299 -4,239	-37%	-$343K	0.09%	72
2014 Q2	$936K	Hold	11,538	–	–	0.13%	71
2014 Q1	$879K	Sell	11,538 -8,578	-43%	-$625K	0.12%	69
2013 Q4	$1.45M	Buy	20,116 +5,005	+33%	+$348K	0.19%	54
2013 Q3	$1.04M	Buy	15,111 +3,673	+32%	+$243K	0.16%	56
2013 Q2	$725K	Buy	+11,438	New	+$744K	0.11%	55

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

CCM

Cullen Capital Management New York $10.2B AUM 27.15% 1-Year Est. Return

HighTower Trust's NVS Position: Q3 2022 in Review

HighTower Trust sold out of Novartis (NVS) in Q3 2022, closing a stake of 38,384 shares — an estimated $4.34M sold.

HighTower Trust first reported a position in NVS in Q2 2013 and held it in 18 quarters. The position peaked at $4.34M in Q2 2022. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

HighTower Trust reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
HighTower Trust sold 38,384 Novartis shares in Q3 2022, an estimated $4.34M.
HighTower Trust first reported a position in Novartis in Q2 2013 and held it in 18 quarters.
HighTower Trust's Novartis position peaked at $4.34M in Q2 2022.
1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on HighTower Trust's 13F filing for Q3 2022, filed 7 Oct 2022.